OncoCyte Corporation
General ticker "OCX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $45.1M (TTM average)
OncoCyte Corporation does not follow the US Stock Market performance with the rate: -23.2%.
Estimated limits based on current volatility of 3.5%: low 2.57$, high 2.76$
Factors to consider:
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.12$, 5.94$]
- 2025-12-31 to 2026-12-31 estimated range: [1.35$, 4.03$]
Financial Metrics affecting the OCX estimates:
- Negative: Non-GAAP EPS, $ of -1.99 <= 0.04
- Negative: Operating cash flow per share per price, % of -40.46 <= 1.76
- Positive: Interest expense per share, $ of 0.01 <= 0.10
- Negative: negative Net income
- Negative: negative Operating income
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term OCX quotes
Long-term OCX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.96MM | $0.22MM | $1.88MM |
| Operating Expenses | $18.95MM | $25.36MM | $62.92MM |
| Operating Income | $-18.00MM | $-25.14MM | $-61.04MM |
| Non-Operating Income | $-0.61MM | $0.28MM | $0.38MM |
| Interest Expense | $0.08MM | $0.05MM | $0.08MM |
| R&D Expense | $7.30MM | $9.29MM | $9.84MM |
| Income(Loss) | $-18.61MM | $-24.86MM | $-60.66MM |
| Other Income(Loss) | $-54.29MM | $-2.93MM | $0.00MM |
| Profit(Loss)* | $-73.44MM | $-30.71MM | $-60.66MM |
| Stockholders Equity | $34.29MM | $20.47MM | $-12.27MM |
| Inventory | $2.12MM | $0.00MM | $0.41MM |
| Assets | $100.09MM | $74.89MM | $35.08MM |
| Operating Cash Flow | $-45.57MM | $-23.32MM | $-20.71MM |
| Capital expenditure | $4.34MM | $0.28MM | $0.52MM |
| Investing Cash Flow | $-4.34MM | $-0.93MM | $-0.51MM |
| Financing Cash Flow | $35.81MM | $12.19MM | $20.43MM |
| Earnings Per Share** | $-13.26 | $-4.01 | $-4.64 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.